Edesa Biotech, Inc.
EDSA
$1.45
-$0.03-2.03%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -131.62% | -4.87% | 14.55% | 3.65% | 44.07% |
| Total Depreciation and Amortization | -41.40% | -49.81% | -46.04% | -4.22% | -3.91% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 330.67% | 62.01% | -50.56% | -55.97% | -81.84% |
| Change in Net Operating Assets | 153.88% | -123.74% | -4,350.00% | -156.94% | 53.94% |
| Cash from Operations | -77.97% | -98.58% | -43.55% | -7.87% | 34.13% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -100.00% | 2,391.08% | 98.86% | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -8.28% | 100.00% | -1,168.12% | -910.53% | 55.96% |
| Cash from Financing | 693.95% | -100.00% | 6,878.22% | 577.63% | -107.61% |
| Foreign Exchange rate Adjustments | -586.27% | 2,097.59% | -186.29% | -491.67% | 87.31% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -56.39% | -102.32% | 940.01% | 148.12% | 8.41% |